Reuters logo
BRIEF-Therapix initiates non-clinical studies for its antibacterial program
October 30, 2017 / 12:54 PM / 20 days ago

BRIEF-Therapix initiates non-clinical studies for its antibacterial program

Oct 30 (Reuters) - Therapix Biosciences Ltd

* Therapix- Initiated non-clinical studies to evaluate efficacy of compound THX-150 with Weizmann Institute of Science & Tel Aviv Sourasky Medical Center​

* Therapix Biosciences Ltd - ‍THX-150 is a pharmaceutical composition of Dronabinol and/or pea along with a selected antibacterial agent​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below